Moderator: Tanya Chawla

Imaging of Hepatocellular Carcinoma: From Diagnosis to Prognosis Prediction  
Sébastien Mulé

Imaging plays a pivotal role in the management of hepatocellular carcinoma (HCC), as contrast-enhanced CT and MRI allow non-invasive diagnosis for HCC by considering the association of imaging features in patients at high risk for HCC. In addition to its diagnostic role, imaging can help phenotype tumour biology and heterogeneity non-invasively. Some imaging signs are associated with pathological factors of poor prognosis such as tumour grade, subtype, or invasiveness. This presentation will explore how imaging techniques can be used to identify tumour phenotypes with varying levels of aggressiveness, offering valuable insights that complement histopathological and molecular data.

At the end of the presentation, participants will be able to do:

• Identify the diagnostic value of imaging features for noninvasive diagnosis of hepatocellular carcinoma (HCC)
• Distinguish the potential of imaging features to provide useful prognostic information
• Discuss the limitations of translating these prognostic imaging features into clinically applicable prognostic markers

Target Audience:

• Radiologist
• Resident

CanMEDS:

• Medical Expert
• Communicator
• Scholar
• Professional

COI:

• None Declared

- - -

Patient Journey
Ysabel Viau

- - - 

Abdominal Manifestations of Therapy
Tanya Chawla

In this presentation, a case-based approach will be employed to illustrate the impact of newer molecular and immunomodulatory therapy in a variety of organ systems in the abdomen. These treatment regimens result in local and systemic changes which in many cases are expected. Accurate characterization and discrimination from residual or recurrent disease are imperative to facilitate timely and appropriate management. A brief overview of radiation related complications will also be undertaken.

At the end of this presentation, participants will be able to:

• Explain the mechanisms of action of molecular targeted and immunomodulatory therapies
• Discuss the spectrum of impact (adverse effects) on organ systems within the abdomen

Target Audience:

• Radiologist
• Resident
• Medical Student

CanMEDS:

• Medical Expert
• Communicator
• Leader

COI: 

• None Declared

- - -

Chest Complications & Side Effects of Therapy
Demetris Patsios

Treatment induced pulmonary injury, and other intrathoracic complications are continuing challenges faced by Radiologists, Pulmonologists and Oncologists in the setting of managing patients undergoing cancer treatment. This presentation will address complications including drug-induced lung or other intrathoracic disease, drug-induced pulmonary toxicity, radiation-induced lung injury, and, in some cases, may reflect a multifactorial effect.

At the end of the presentation, participants will be able to do:

• Identify common imaging patterns associated with treatment-related pulmonary injuries
• Recognize medications linked to drug-induced pulmonary injury and distinguish imaging features of radiation-induced lung injury
• Describe the most frequent imaging patterns observed in drug-induced pulmonary injury

Target Audience:

• Radiologist
• Resident
• Medical Student

CanMEDS:

• Medical Expert
• Communicator
• Collaborator
• Leader
• Health Advocate
• Scholar
• Professional 

COI: 

• None Declared

- - -

Treatment-Induced Toxicity of the Central Nervous System
Carlos Torres

This presentation will review some of the common and rare imaging abnormalities affecting the central nervous system during and after cancer treatment.

At the end of this presentation, participants will be able to:

• Recognize common and rare imaging findings involving the brain and/or spinal cord secondary to cancer therapies.

Target Audience:

• Radiologist
• Resident
• Medical Student

CanMEDS:

• Medical Expert
• Collaborator
• Health Advocate
• Professional

COI:

• None Declared

- - -